Bioorganic and medicinal chemistry letters p. 141 - 144 (1999)
Update date:2022-08-03
Topics:
Chu, Guo-Hua
Peters, Amy
Selcer, Kyle W.
Li, Pui-Kai
We report the development of (E)- and (Z)-4-hydroxytamoxifen sulfamates as estrone sulfatase inhibitors, potential therapeutic agents for the treatment of breast cancer. Both compounds competitively inhibit estrone sulfatase isolated from rat liver with apparent Ki of 35.9 μM for (E)-4-hydroxytamoxifen sulfamate and an apparent Ki of >500 μM for the (Z) isomer.
View MoreTaizhou Crene Biotechnology co.ltd
Contact:86-576-88813233 88205808
Address:Economic Developed Zone of Taizhou Zhejiang China
JIANGXI AIFEIMU TECHNOLOGY CO.，LTD
Contact:+86-570-6040289
Address:FINECHEMICAL PARK,ZIBU TOWN,WANNIAN COUNTY,JIANGXI PROV.,CHINA,ZIP
Landz International Company Ltd.
Contact:0086-21-58891610
Address:985 Dongfang Road, Pudong, Shanghai 200122 China
Contact:86-571-86737118-8689
Address:No.69, 12 Street, HEDA, Hangzhou, Zhejiang, China
Contact:+8613400661290
Address:No 908,Kangwan Rd, Liuyang Economic
Doi:10.1021/jo9613601
(1997)Doi:10.1021/ja01207a035
(1946)Doi:10.1016/S0040-4039(96)02075-8
(1996)Doi:10.1016/S0960-894X(99)00187-0
(1999)Doi:10.1016/S0968-0896(02)00612-0
(2003)Doi:10.1021/ja963295i
(1997)
